48 Result(s)

Article

Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity

S Garciaz, D Coso, J-M Schiano de Collela, F Broussais… in Bone Marrow Transplantation (2016)

Article

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years

Autologous hematopoietic cell transplantation (AHCT) is a standard of care in multiple myeloma (MM) patients aged <65 years. To understand age-related trends in utilisation and outcome of AHCT, we analysed 53 ...

H W Auner, R Szydlo, J Hoek, H Goldschmidt, A M Stoppa… in Bone Marrow Transplantation (2015)

Article

Automated washing of autologous hematopoietic stem cell grafts after thawing does not impair engraftment

B Calmels, A Drezet, C Huynh, A Autret, A-M Stoppa… in Bone Marrow Transplantation (2014)

Article

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

Deletions of the 1p region appear as a pejorative prognostic factor in multiple myeloma patients (especially 1p22 and 1p32 deletions) but there is a lack of data on the real impact of 1p abnormalities on an im...

B Hebraud, X Leleu, V Lauwers-Cances, M Roussel, D Caillot, G Marit, L Karlin… in Leukemia (2014)

Article

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

X Leleu, G Fouquet, B Hebraud, M Roussel, D Caillot, M L Chrétien, B Arnulf… in Leukemia (2013)

Article

Minor clone provides a reservoir for relapse in multiple myeloma

Recent studies have provided direct evidence for genetic variegation in subclones for various cancer types. However, little is known about subclonal evolutionary processes according to treatment and subsequent...

F Magrangeas, H Avet-Loiseau, W Gouraud, L Lodé, O Decaux, P Godmer, L Garderet… in Leukemia (2013)

Article

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

We report the first randomized study comparing early hospital discharge with standard hospital-based follow-up after high-dose chemotherapy (HDCT) and PBSCT. Patients aged 18–65 years, with an indication of PB...

C Faucher, A G Le Corroller Soriano, B Esterni, N Vey… in Bone Marrow Transplantation (2012)

Article

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

In this retrospective study, 63 patients >60 years with hematological malignancies and treated with allo-SCT and with reduced-intensity conditioning (RIC) were reviewed. A total of 51% of patients suffered fro...

L Castagna, S Fürst, N Marchetti, J El Cheikh, C Faucher… in Bone Marrow Transplantation (2011)

Article

Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial

P Moreau, C Hulin, G Marit, D Caillot, T Facon, P Lenain, C Berthou, B Pégourié… in Leukemia (2010)

Article

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison

M Mohty, H de Lavallade, J El-Cheikh, P Ladaique, C Faucher, S Fürst, N Vey… in Leukemia (2009)

Article

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma

The aim of this retrospective analysis was to assess the benefit of reduced-intensity conditioning allo SCT (RIC allo-SCT) in a cohort of 32 relapsed multiple myeloma (MM) patients. A total of 19 patients had ...

H de Lavallade, J El-Cheikh, C Faucher, S Fürst, A-M Stoppa… in Bone Marrow Transplantation (2008)

Article

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation

The use of high-dose corticosteroids for graft-versus-host disease (GVHD) treatment represents a major risk factor for long-term invasive fungal infections. The aim of this study was to investigate the safety ...

J El-Cheikh, C Faucher, S Fürst, S Duran, P Berger, N Vey… in Bone Marrow Transplantation (2007)

Article

A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma

The potential benefit of rituximab as adjuvant to high-dose therapy (HDT) has been investigated in patients under 60 years with poor-risk (age-adjusted international prognostic index at 2–3) CD20+ diffuse larg...

D Coso, C Sebban, O Boulat, P Biron, J Rey, T Aurran… in Bone Marrow Transplantation (2006)

Article

Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission

H de Lavallade, C Faucher, S Fürst, J El-Cheikh, N Vey… in Bone Marrow Transplantation (2006)

Article

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

We analyzed the incidence, presenting features, risk factors of extramedullary (EM) relapse occurring in acute promyelocytic leukemia (APL) treated with all-trans retinoic acid (ATRA) and chemotherapy by using a ...

S de Botton, M A Sanz, S Chevret, H Dombret, G Martin, X Thomas, J D Mediavilla… in Leukemia (2006)

Article

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

Internal tandem duplications (ITDs) of the FLT3 gene have been observed in about 35% of APL cases. If FLT3-ITD is associated with a worse outcome in patients with acute myeloid leukemia (AML) in general, its prog...

C Callens, S Chevret, J-M Cayuela, B Cassinat, E Raffoux, S de Botton, X Thomas… in Leukemia (2005)